Convatec GroupFRA:2CVU +2.62%77 FCF Margin % is 15.80% as of Dec. 2025, which is 33% above its 10-year median of 11.85. GuruFocus rates FRA:2CVU with a GF Score™ of 77/100 and a GF Value™ of €11.76. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Convatec Group ranks better than 77.3% on this metric.
The historical rank and industry rank for Convatec Group's FCF Margin % or its related term are showing as below:
FRA:2CVU'
s FCF Margin % Range Over the Past 10 Years
Min: 0.41 Med: 11.85 Max: 18.63
Current: 11.65
During the past 13 years, the highest FCF Margin % of Convatec Group was 18.63%. The lowest was 0.41%. And the median was 11.85%.
FRA:2CVU's FCF Margin % is ranked better than 77.3% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs FRA:2CVU: 11.65
Convatec Group FCF Margin % Related Terms
Convatec Group FCF Margin % Historical Data
* Premium members only.
The historical data trend for Convatec Group's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2CVU vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Convatec Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Convatec Group FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Convatec Group's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Convatec Group (FRA:2CVU) has a FCF Margin % of 15.80% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Convatec Group and its competitors. This is 33% above median its historical median of 11.85. Over the past decade, Convatec Group's FCF Margin % has ranged from 0.41 to 18.63. According to the industry distribution chart, Convatec Group ranks #185 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 22.7%.
Is Convatec Group's FCF Margin % too high?
Convatec Group's current FCF Margin % of 15.80% is 33% above median its 10-year median of 11.85. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 18.63. Based on the distribution chart, Convatec Group ranks #185 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Convatec Group has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Convatec Group ranks #185 out of 815 companies for FCF Margin %. This places Convatec Group in the top 23% of its industry — outperforming the majority of peers. Historically, Convatec Group's own FCF Margin % has ranged from 0.41 to 18.63 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Convatec Group and its competitors. Convatec Group's current FCF Margin % is 15.80%, which is 33% above median its own 10-year median of 11.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Convatec Group (FRA:2CVU) has a current FCF Margin % of 15.80%. The stock's GF Value™ is €11.76, compared to a current price of €9.80 — trading 16.7% below its estimated fair value. The current FCF Margin % is 15.80%, which is 33% above median its 10-year median of 11.85. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Convatec Group (FRA:2CVU), the current FCF Margin % is 15.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Convatec Group (FRA:2CVU) Overvalued in 2026?
Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued.
The current stock price of €9.80 is trading 16.7% below its estimated GF Value™ of €11.76.
Key valuation signals for FRA:2CVU:
FCF Margin %: 15.80% (33% above median its 10-year median of 11.85)
GF Value™: €11.76 vs. price of €9.80 (16.7% below fair value)
No single metric tells the full story. See the FRA:2CVU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score
Get the complete analysis for FRA:2CVU
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2CVU has been successfully added to your 
